基于纳米颗粒靶向细菌的策略及机制的研究进展

doi:10.3969/j.issn.1674-8115.2022.06.018

摘要/Abstract

摘要：

抗生素耐药危机是全球公共卫生中最紧迫的问题之一。为了解决细菌对抗生素的耐药危机，近年来越来越多的生物纳米材料被应用于抗菌领域。纳米颗粒（nanoparticles，NPs）是一类大小在纳米尺度的材料，与传统抗菌药物相比具有独特的优势，但NPs应用于人体依然面临靶向性不高以及对其他组织脏器的损害问题。靶向治疗除了能提高疗效外，还允许使用较低浓度的高毒性药物，从而减少药物毒性和健康组织的不良反应，因此如何提高NPs对细菌的靶向性，是当今医疗卫生领域面临的重要问题。该文首先对NPs做一概述，然后从表面功能化、环境响应和细胞膜仿生修饰3种常用的细菌靶向策略出发，介绍其基本机制及最新研究成果，并总结每种策略的优劣势以及未来主要的发展方向，以期提供该领域发展情况的大略图景，为抗菌药物的靶向治疗策略提供新的思路。

关键词: 纳米颗粒, 靶向, 表面功能化, 刺激响应, 仿生

Abstract:

The crisis of antibiotic resistance is one of the most pressing problems in global public health. To solve the crisis of antibiotic resistance, more and more biological nanomaterials are applied to antimicrobial in recent years. Nanoparticles (NPs) are a class of nanoscale materials with unique advantages compared with traditional antibacterial drugs. However, the application of nanoparticles still faces the dilemma of poor targeting ability and the possible damage to normal tissue. In addition to improving efficacy, targeted therapies allow us to use lower concentrations of highly toxic drugs, thereby reducing the toxic side effects on healthy tissue. Therefore, how to improve the targeting of NPs to bacteria is an important issue today. This article will give an overall introduction to nanoparticles first. Surface modification, stimuli-responsiveness and biomimetic modification of cell membrane, three common bacterial targeting strategies will be introduced later, including their basic mechanisms and the latest findings. The advantages and disadvantages of the three strategies and their future direction will also be summarized. A general picture of the developments in this field will be provided to readers, and it is hoped that new ideas for targeting bacteria will emerge in the future.

Key words: nanoparticle (NP), targeting, surface modification, stimuli-responsive, biomimetics

中图分类号:

R318.08

骆智渊, 石亭旺, 阮泽松, 陈云丰. 基于纳米颗粒靶向细菌的策略及机制的研究进展[J]. 上海交通大学学报（医学版）, 2022, 42(6): 819-824.

LUO Zhiyuan, SHI Tingwang, RUAN Zesong, CHEN Yunfeng. Reaearch progress of strategies and mechanisms of targeting bacteria based on nanoparticles[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 819-824.

图/表 1

参考文献 53

1	NAYLOR N R, ATUN R, ZHU N N, et al. Estimating the burden of antimicrobial resistance: a systematic literature review[J]. Antimicrob Resist Infect Control, 2018, 7: 58.
2	BAPTISTA P V, MCCUSKER M P, CARVALHO A, et al. Nano-strategies to fight multidrug resistant bacteria-“A battle of the titans”[J]. Front Microbiol, 2018, 9: 1441.
3	MILLER K P, WANG L, BENICEWICI B C, et al. Inorganic nanoparticles engineered to attack bacteria[J]. Chem Soc Rev, 2015. 44(21): 7787-7807.
4	PAUL E. Chemotherapeutische trypanosomen-studien[J]. Berliner Klinische Wochenschrift, 1907, 44: 233-236.
5	GUIDO C, MAIORANO G, CORTESE B, et al. Biomimetic nanocarriers for cancer target therapy[J]. Bioengineering (Basel), 2020, 7(3): 111.
6	LI J L, CHEN C Y, XIA T. Understanding nanomaterial-liver interactions to facilitate the development of safer nanoapplications[J]. Adv Mater, 2022, 34(11): e2106456.
7	WANG W, LI P F, XIE R, et al. Designable micro-/ nano-structured smart polymeric materials[J]. Adv Mater, 2021: e2107877. DOI: 10.1002/adma.202107877.
8	NATAN M, BANIN E. From nano to micro: using nanotechnology to combat microorganisms and their multidrug resistance[J]. FEMS Microbiol Rev, 2017, 41(3): 302-322.
9	YIN I X, ZHANG J, ZHAO I S, et al. The antibacterial mechanism of silver nanoparticles and its application in dentistry[J]. Int J Nanomedicine, 2020, 15: 2555-2562.
10	DONG X L, LIANG W X, MEZIANI M J, et al. Carbon dots as potent antimicrobial agents[J]. Theranostics, 2020, 10(2): 671-686.
11	AUGUSTINE R, KALVA N, KIM H N, et al. PH-responsive polypeptide-based smart nano-carriers for theranostic applications[J]. Molecules, 2019, 24: 2961.
12	LANDIS R F, GUPTA A, LEE Y W, et al. Cross-linked polymer-stabilized nanocomposites for the treatment of bacterial biofilms[J]. ACS Nano, 2017, 11(1): 946-952.
13	MAKABENTA J M V, NABAWY A, LI C H, et al. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections[J]. Nat Rev Microbiol, 2021, 19(1): 23-36.
14	ZHANG J L, XIANG Q Q, SHEN L, et al. Surface charge-dependent bioaccumulation dynamics of silver nanoparticles in freshwater algae[J]. Chemosphere, 2020, 247: 125936.
15	LAM S J, O'BRIEN-SIMPSON N M, PANTARAT N, et al. Combating multidrug-resistant gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers[J]. Nat Microbiol, 2016, 1(11): 16162.
16	HUO S D, JIANG Y, GUPTA A, et al. Fully zwitterionic nanoparticle antimicrobial agents through tuning of core size and ligand structure[J]. ACS Nano, 2016, 10(9): 8732-8737.
17	ELBOURNE A, CHEESEMAN S, ATKIN P, et al. Antibacterial liquid metals: biofilm treatment via magnetic activation[J]. ACS Nano, 2020, 14(1): 802-817.
18	JIN K, LUO Z M, ZHANG B, et al. Biomimetic nanoparticles for inflammation targeting[J]. Acta Pharm Sin B, 2018, 8(1): 23-33.
19	WANG H J, SONG Z Y, LI S J, et al. One stone with two birds: functional gold nanostar for targeted combination therapy of drug-resistant Staphylococcus aureus infection[J]. ACS Appl Mater Interfaces, 2019, 11(36): 32659-32669.
20	KANG S, PARK T, CHEN X Y, et al. Tunable physiologic interactions of adhesion molecules for inflamed cell-selective drug delivery[J]. Biomaterials, 2011, 32(13): 3487-3498.
21	LEHAR S M, PILLOW T, XU M, et al. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus[J]. Nature, 2015, 527(7578): 323-328.
22	GALANZHA E I, SHASHKOV E, SARIMOLLAOGLU M, et al. In vivo magnetic enrichment, photoacoustic diagnosis, and photothermal purging of infected blood using multifunctional gold and magnetic nanoparticles[J]. PLoS One, 2012, 7(9): e45557.
23	CHEN L F, XING S H, LEI Y L, et al. A glucose-powered activatable nanozyme breaking pH and H₂O₂ limitations for treating diabetic infections[J]. Angew Chem Int Ed Engl, 2021, 60(44): 23534-23539.
24	YATVIN M B, WEINSTEIN J N, DENNIS W H, et al. Design of liposomes for enhanced local release of drugs by hyperthermia[J]. Science, 1978, 202(4374): 1290-1293.
25	AMOLI-DIVA M, SADIGHI-BONABI R, POURGHAZI K. Laser-assisted triggered-drug release from silver nanoparticles-grafted dual-responsive polymer[J]. Mater Sci Eng C Mater Biol Appl, 2017, 76: 536-542.
26	MEEKER D G, JENKINS S V, MILLER E K, et al. Synergistic photothermal and antibiotic killing of biofilm-associated Staphylococcus aureus using targeted antibiotic-loaded gold nanoconstructs[J]. ACS Infect Dis, 2016, 2(4): 241-250.
27	BORZENKOV M, MOROS M, TORTIGLIONE C, et al. Fabrication of photothermally active poly(vinyl alcohol) films with gold nanostars for antibacterial applications[J]. Beilstein J Nanotechnol, 2018, 9: 2040-2048.
28	MOHAPATRA A, HARRIS M A, LEVINE D, et al. Magnetic stimulus responsive vancomycin drug delivery system based on chitosan microbeads embedded with magnetic nanoparticles[J]. J Biomed Mater Res B Appl Biomater, 2018, 106(6): 2169-2176.
29	GEILICH B M, GELFAT I, SRIDHAR S, et al. Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication[J]. Biomaterials, 2017, 119: 78-85.
30	HARRIS M, AHMED H, BARR B, et al. Magnetic stimuli-responsive chitosan-based drug delivery biocomposite for multiple triggered release[J]. Int J Biol Macromol, 2017, 104(Pt B): 1407-1414.
31	DAS S S, BHARADWAJ P, BILAL M, et al. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis[J]. Polymers, 2020, 12(6): 1397.
32	WU J H, LI F Y, HU X, et al. Responsive assembly of silver nanoclusters with a biofilm locally amplified bactericidal effect to enhance treatments against multi-drug-resistant bacterial infections[J]. ACS Cent Sci, 2019, 5(8): 1366-1376.
33	KALHAPURE R S, JADHAV M, RAMBHAROSE S, et al. pH-responsive chitosan nanoparticles from a novel twin-chain anionic amphiphile for controlled and targeted delivery of vancomycin[J]. Colloids Surf B Biointerfaces, 2017, 158: 650-657.
34	WU Y, SONG Z Y, WANG H J, et al. Endogenous stimulus-powered antibiotic release from nanoreactors for a combination therapy of bacterial infections[J]. Nat Commun, 2019, 10(1): 4464.
35	DONG X Y, ZHANG C Y, JIN G, et al. Targeting of nanotherapeutics to infection sites for antimicrobial therapy[J]. Adv Ther (Weinh), 2019, 2(11): 1900095.
36	MA B X, XU H, ZHUANG W H, et al. Reactive oxygen species responsive theranostic nanoplatform for two-photon aggregation-induced emission imaging and therapy of acute and chronic inflammation[J]. ACS Nano, 2020, 14(5): 5862-5873.
37	WANG Z, LIU X Y, DUAN Y W, et al. Infection microenvironment-related antibacterial nanotherapeutic strategies[J]. Biomaterials, 2022, 280: 121249.
38	LI L L, XU J H, QI G B, et al. Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery[J]. ACS Nano, 2014, 8(5): 4975-4983.
39	CHEN M H, XIE S Z, WEI J J, et al. Antibacterial micelles with vancomycin-mediated targeting and pH/lipase-triggered release of antibiotics[J]. ACS Appl Mater Interfaces, 2018, 10(43): 36814-36823.
40	CANAPARO R, FOGLIETTA F, GIUNTINI F, et al. Recent developments in antibacterial therapy: focus on stimuli-responsive drug-delivery systems and therapeutic nanoparticles[J]. Molecules, 2019, 24(10): 1991.
41	HU C M J, ZHANG L, ARYAL S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform[J]. Proc Natl Acad Sci USA, 2011, 108(27): 10980-10985.
42	WANG K Y, LEI Y T, XIA D L, et al. Neutrophil membranes coated, antibiotic agent loaded nanoparticles targeting to the lung inflammation[J]. Colloids Surf B Biointerfaces, 2020, 188: 110755.
43	WANG C, WANG Y L, ZHANG L L, et al. Pretreated macrophage-membrane-coated gold nanocages for precise drug delivery for treatment of bacterial infections[J]. Adv Mater, 2018, 30(46): e1804023.
44	WEI X L, RAN D N, CAMPEAU A, et al. Multiantigenic nanotoxoids for antivirulence vaccination against antibiotic-resistant gram-negative bacteria[J]. Nano Lett, 2019, 19(7): 4760-4769.
45	HU Q Y, SUN W J, QIAN C G, et al. Relay drug delivery for amplifying targeting signal and enhancing anticancer efficacy[J]. Adv Mater, 2017, 29(13): 1605803.
46	GAO F, XU L L, YANG B Q, et al. Kill the real with the fake: eliminate intracellular Staphylococcus aureus using nanoparticle coated with its extracellular vesicle membrane as active-targeting drug carrier[J]. ACS Infect Dis, 2019, 5(2): 218-227.
47	DEHAINI D, WEI X L, FANG R H, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization[J]. Adv Mater, 2017, 29(16): 1606209.
48	LI J, ANGSANTIKUL P, LIU W, et al. Biomimetic platelet-camouflaged nanorobots for binding and isolation of biological threats[J]. Adv Mater, 2018, 30(2). DOI:10.1002/adma.201704800.
49	MOLINARO R, CORBO C, MARTINEZ J O, et al. Biomimetic proteolipid vesicles for targeting inflamed tissues[J]. Nat Mater, 2016, 15(9): 1037-1046.
50	BOROVIČKA J, METHERINGHAM W J, MADDEN L A, et al. Photothermal colloid antibodies for shape-selective recognition and killing of microorganisms[J]. J Am Chem Soc, 2013, 135(14): 5282-5285.
51	DALLE VEDOVE E, COSTABILE G, MERKEL O M. Mannose and mannose-6-phosphate receptor-targeted drug delivery systems and their application in cancer therapy[J]. Adv Healthc Mater, 2018, 7(14): e1701398.
52	PI J, SHEN L, YANG E Z, et al. Macrophage-targeted isoniazid-selenium nanoparticles promote antimicrobial immunity and synergize bactericidal destruction of tuberculosis bacilli[J]. Angew Chem Int Ed Engl, 2020, 59(8): 3226-3234.
53	PI J, SHEN L, SHEN H B, et al. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency[J]. Mater Sci Eng C Mater Biol Appl, 2019, 103: 109777.

Category	Advantages	Disadvantages
Surface modification	High targeting efficiency，various forms	Short circulation， safety problems
Stimuli-responsive	Diverse conditions， simpler and more reproducible	Technology limitations to provide stimulus
Biomimetic modification of cell membrane	Prolonged circulation time， cell-specific targeting， detoxification	Technological complexity， lack of raw materials

Category	Advantages	Disadvantages
Surface modification	High targeting efficiency，various forms	Short circulation， safety problems
Stimuli-responsive	Diverse conditions， simpler and more reproducible	Technology limitations to provide stimulus
Biomimetic modification of cell membrane	Prolonged circulation time， cell-specific targeting， detoxification	Technological complexity， lack of raw materials

[1]	孟靖, 谢玉婷, 左佳鑫, 熊屏. 纳米工程化T细胞体系的构建及其对口腔鳞状细胞癌的体外治疗研究[J]. 上海交通大学学报（医学版）, 2025, 45(7): 866-873.
[2]	潘抒凡, 杨栋磊, 王鹏飞. 基于纳米孔Cas9靶向测序的金黄色葡萄球菌快速检测与分型[J]. 上海交通大学学报（医学版）, 2025, 45(6): 774-783.
[3]	梁效宁, 石亭旺, 陈云丰. 小菌落变异株的致病机制及治疗研究进展[J]. 上海交通大学学报（医学版）, 2025, 45(6): 784-791.
[4]	禹恺, 帅哲玮, 黄洪军, 罗艳. 小胶质细胞在中枢神经系统炎症性疾病中的作用和机制研究进展[J]. 上海交通大学学报（医学版）, 2025, 45(5): 630-638.
[5]	罗文, 吕明君, 张珍, 张雪, 姚志荣. 自噬在皮肤黑色素瘤中的双重效应及耐药中的作用研究进展[J]. 上海交通大学学报（医学版）, 2025, 45(2): 233-240.
[6]	唐珺倩, 李本尚. 儿童高危细胞遗传学B系急性淋巴细胞白血病治疗新进展[J]. 上海交通大学学报（医学版）, 2025, 45(10): 1390-1399.
[7]	张勇, 李伟宏, 程志鹏, 王斌, 王思珩, 王毓斌. 受体相互作用蛋白激酶1调节癌症进展和免疫反应的研究现状[J]. 上海交通大学学报（医学版）, 2024, 44(6): 788-794.
[8]	徐文晖, 杨畅, 李瑞卿, 卞京, 李夏伊, 郑磊贞. 干扰素调节因子3促结直肠癌细胞增殖与侵袭相关探索[J]. 上海交通大学学报（医学版）, 2024, 44(3): 301-311.
[9]	丁艳玲, 李杰, 袁军, 李燕. 慢性淋巴细胞白血病靶向治疗的研究进展[J]. 上海交通大学学报（医学版）, 2024, 44(2): 264-270.
[10]	唐思洁, 糜坚青. 抗体药物偶联物在血液肿瘤中的临床应用研究进展[J]. 上海交通大学学报（医学版）, 2024, 44(12): 1607-1614.
[11]	方馨悦, 石岚, 夏思易, 王佳璇, 吴英理, 何珂骏. Menin-MLL蛋白相互作用及相关抑制剂在MLL基因重排白血病中应用的研究进展[J]. 上海交通大学学报（医学版）, 2024, 44(10): 1287-1298.
[12]	周婉桢, 滕银成. 非经典Wnt通路在卵巢癌中的作用与潜在治疗意义研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(8): 1056-1063.
[13]	梅艳青, 韩雨洁, 翁文筠, 张蕾, 唐玉杰. 靶向抑制CDK12/13在高级别胶质瘤中的体外治疗效果和作用分子机制探究[J]. 上海交通大学学报（医学版）, 2023, 43(5): 545-559.
[14]	徐瀛濂, 田静, 张翔, 赵顺英. 气道上皮细胞在哮喘发病机制中的作用研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(5): 619-623.
[15]	魏兰懿, 薛晓川, 陈君君, 杨全军, 王梦月, 韩永龙. 骨肉瘤免疫微环境中肿瘤相关巨噬细胞及其靶向治疗的研究进展[J]. 上海交通大学学报（医学版）, 2023, 43(5): 624-630.